Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
about
Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPasesRas superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?Ral GTPases: crucial mediators of exocytosis and tumourigenesisRal GTPases in tumorigenesis: emerging from the shadowsAberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanismsSynthesis of novel Ral inhibitors: An in vitro and in vivo studyDiscovery and characterization of small molecules that target the GTPase RalThe Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic targetTranscriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.Phosphorylation of RalB is important for bladder cancer cell growth and metastasisRalBP1 is necessary for metastasis of human cancer cell linesConstruction and analysis of protein-protein interaction networks based on proteomics data of prostate cancerTDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.ERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells.Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.Ral activation promotes melanomagenesis.Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer.Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent.Ral small GTPase signaling and oncogenesis: More than just 15minutes of fameProstate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancerStatins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteinsLoss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasisDissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation.Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.Inhibition of Ras for cancer treatment: the search continues.Mechanisms regulating colorectal cancer cell metastasis into liver (Review).Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapsePGE2 promotes renal carcinoma cell invasion through activated RalA.RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with RalGDSMouse models for studying prostate cancer bone metastasis.EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.Androgen receptor regulates SRC expression through microRNA-203KLF4 functions as an activator of the androgen receptor through reciprocal feedback.Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.Activation and involvement of Ral GTPases in colorectal cancer.
P2860
Q24337797-CFB21A13-733F-4A4E-BEB2-E198FE66096CQ27690752-18EB2D6D-42CB-4882-B199-1BA8A8187906Q28259292-4A6A49C1-32EA-457D-BC2A-C81F8E6005F0Q28294053-73919386-C3B4-454A-9B64-F557BCFBA6EEQ28384212-E35126B4-0D64-4175-B672-FCFEFCEA3102Q28817036-F87B7E4E-21A0-4E0D-808A-B918AFA41F13Q30366783-D0D360E9-A57C-4AB0-8509-B68745D14E7EQ30415154-2E831895-A985-46B4-B5AB-0E0ECB3FF5E1Q30416201-0A8E40B3-C997-4DEE-B129-45751D23BF51Q30429890-94B2ABDA-D0B9-415E-A654-F2357DC6D8B0Q30433862-FBE400D3-A020-4180-93B4-41BE58D92C2EQ31086270-62842B42-3D8F-4EC3-B3EB-5B87FB3E2B8FQ33348778-BFCE25DE-6D91-429C-BA8B-709E0566D27BQ33768865-41B58BFC-7BF8-4700-82F3-C8E5CF09371BQ33977056-DB184E50-25D8-43BD-808F-A3B86C933B82Q34086528-3734890E-A554-42AE-8898-233A79D98C9EQ34340825-12F8C0D9-49FB-4F44-A308-6B98AFDA86CDQ34344714-E633AACA-5568-423D-996B-6DDDE62E1F31Q34363605-66313C3A-1A3D-466E-BF4F-9074B9BA76AEQ35070005-2AED805C-5BCD-4531-A636-09D8F927E386Q35083727-F295FB60-2CEB-44DC-AADC-C8F3F8B92276Q35238489-6242AC2C-CBA7-4D39-8F2B-664CAF71B728Q35264079-4D9C4CDC-7B50-4275-BB2D-AFC6DD80EB25Q35573029-09C40709-FA58-4F7C-85E2-D163864F2FF6Q35600629-5CA91DFE-FE8A-4512-AF89-EA431BD74F3DQ35779541-B0415979-7438-4EEC-8122-0BD356D05A53Q35871737-C3A19743-96CE-4AF1-ABDF-B9523BF37B8FQ35944601-9BE25CC1-8984-4A06-9740-FC98009B956CQ35995311-5FECF0EE-034C-45E1-849A-EFBA268479FDQ36129973-439CDBBD-99DB-4ED7-AAB8-37836D3E42A6Q36170200-97CC25BB-30E8-4E0D-B635-2889B9AA29F4Q36246430-2127322E-B0F7-4577-B945-092975384EA7Q36590497-F6E4ABE3-87D8-4EDF-8663-70E951F45E04Q37007828-F6EC2069-4C04-4AD0-B4ED-B92A62E9F2E2Q37295473-1FFC56DE-4EE5-464D-B582-2521F60A9AA7Q37525801-2736C183-4E6B-4776-87EA-D49A59AEA174Q37536632-2E740691-1900-402E-8A36-7EF3FF9409BFQ37603357-4B2C96FA-85D7-452C-B056-B53B623483F6Q38306683-D97F8103-3C93-4D4B-9790-6A2E5F5976CAQ38338335-AA1E8261-E859-4454-A11C-613319020662
P2860
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@ast
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@en
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@nl
type
label
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@ast
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@en
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@nl
prefLabel
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@ast
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@en
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@nl
P2093
P2860
P3181
P356
P1476
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
@en
P2093
Claire Pollock
JuanJuan Yin
Kathleen Kelly
Michael Oberst
Monika Chock
Philip Martin
P2860
P304
P3181
P356
10.1128/MCB.00955-07
P407
P577
2007-08-20T00:00:00Z